An investigation for investors in Targacept , Inc. (NASDAQ:TRGT) shares over potential securities laws violations by Targacept was announced and NASDAQ:TRGT stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/18/2013 -- An investigation on behalf of investors of Targacept , Inc. (NASDAQ:TRGT) shares over potential securities laws violations by Targacept and certain of its directors and officers in connection certain financial statements was announced .
If you purchased shares of Targacept , Inc. (NASDAQ:TRGT), you have certain options and you should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Targacept , Inc. (NASDAQ:TRGT) concerning whether a series of statements by Targacept ,. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Targacept , Inc. reported that its annual Total Revenue declined from $97.64 million in 2011 to $57.86 million in 2012 while its Net Loss decreased from $8.53 million in 2011 to $7.00 million in 2012.
Shares of Targacept , Inc. grew from under $ in late 2012 to as high as $6.08 per share on December 16, 2013.
Then on December 16, 2013, Targacept , Inc. announced negative Top-Line Results from Phase 2b Clinical Trial of TC-5619 in Schizophrenia.
Shares of Targacept , Inc. dropped on December 17, 2013, to as low as $3.91 per share.
Those who purchased shares of Targacept , Inc. (NASDAQ:TRGT), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)